IERARDI, ENZO GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 6.345
EU - Europa 4.671
AS - Asia 3.229
SA - Sud America 356
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 14.654
Nazione #
US - Stati Uniti d'America 6.299
CN - Cina 1.494
IE - Irlanda 1.303
UA - Ucraina 1.036
SG - Singapore 887
SE - Svezia 726
RU - Federazione Russa 619
BR - Brasile 298
HK - Hong Kong 296
FR - Francia 263
IT - Italia 259
TR - Turchia 220
IN - India 185
FI - Finlandia 180
GB - Regno Unito 138
DE - Germania 78
VN - Vietnam 58
AR - Argentina 26
CA - Canada 23
IQ - Iraq 19
MX - Messico 14
EU - Europa 13
ZA - Sudafrica 13
NL - Olanda 12
PL - Polonia 11
ES - Italia 10
EC - Ecuador 9
BD - Bangladesh 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
PK - Pakistan 7
AZ - Azerbaigian 5
BE - Belgio 5
CZ - Repubblica Ceca 5
JP - Giappone 5
MA - Marocco 5
AT - Austria 4
AU - Australia 4
EG - Egitto 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
CO - Colombia 3
ID - Indonesia 3
IL - Israele 3
LT - Lituania 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.654
Città #
Dublin 1.301
Chandler 917
San Jose 793
Jacksonville 734
Dearborn 580
Ashburn 413
Singapore 377
Nanjing 376
Nyköping 374
Hong Kong 294
Wilmington 218
Beijing 186
Santa Clara 157
Princeton 146
San Mateo 144
Lauterbourg 123
Nanchang 115
Boardman 114
Woodbridge 85
Kunming 74
Hebei 69
Shenyang 69
Moscow 67
Ann Arbor 63
Dallas 63
Tianjin 59
Des Moines 58
Jiaxing 54
Changsha 50
Guangzhou 44
Los Angeles 42
Shanghai 36
Hilden 34
Helsinki 33
Hangzhou 32
New York 32
The Dalles 32
Jinan 30
Seattle 29
Stevenage 28
São Paulo 24
Ho Chi Minh City 19
Pune 19
Changchun 17
Council Bluffs 16
Ningbo 15
Rome 15
Rio de Janeiro 14
Taizhou 14
Brooklyn 13
Orem 13
Dong Ket 12
Norwalk 12
Shenzhen 12
Auburn Hills 11
Boston 11
Philadelphia 11
Zhengzhou 11
Frankfurt am Main 10
Hanoi 10
Lanzhou 10
London 9
Salt Lake City 9
Warsaw 9
Wuhan 9
Chennai 8
Milan 8
Nuremberg 8
Wuxi 8
Amsterdam 7
Baghdad 7
Belo Horizonte 7
Hefei 7
Phoenix 7
Quanzhou 7
Bari 6
Johannesburg 6
Atlanta 5
Baku 5
Bologna 5
Brasília 5
Brussels 5
Florence 5
Fuzhou 5
Hanover 5
Montreal 5
Napoli 5
Porto Alegre 5
Quito 5
Saint Petersburg 5
Tokyo 5
Borås 4
Contagem 4
Dhaka 4
Fairfield 4
Hillsboro 4
Jeddah 4
Mumbai 4
Orange 4
San Francisco 4
Totale 8.962
Nome #
LA COLITE SEGMENTARIA ASSOCIATA AI DIVERTICOLI: USO DEL DEL bECLOMETASONE dipropionatoNELLE FORME EMORRAGICHE 322
Helicobacter Heilmannii: un nuovo batterio dello stomaco. Come si ricerca e suo ruolo nella pratica clinica 163
"Clarithromycin-resistant genotypes and eradication of Helicobacter pylori." 141
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. 139
Argon plasma coagulation in the treatment of haemorragic solitary ulcer syndrome. 138
A case of adverse reaction potentially related to a microbubble contrast agent for ultrasonography. 135
Argon plasma coagulation of haemorragic solitary rectal ulcer syndrome. 131
57. M Barone, E Maiorano, R Ladisa, A Pece, P Berloco, M Strazzabosco, ML Caruso, AM Valentini, E Ierardi, A Di Leo, A Francavilla. Ursodeoxycholate further increases bile duct cell proliferative response induced by partial bile duct ligation in rats. 129
H. pylori antibiotic resistance and 13C urea breath test values. J Med Microbiol. 2010 Jan 21. 129
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. 125
Peritoneo-venous shunting for ascites: a five year experience with LeVeen and Denver shunts. 124
Modulation of rat Hepatocyte proliferation by bile salts: in vitro and in vivo studies 124
Circadian rhythm of hepatic estrogen receptors 123
H. pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years 122
Binding of Campylobacter pylori to human peripheral blood lymphocytes 120
Helicobacter pylori and chronic antral erosions: our experience. 120
"Nutrizione in Gastroenterologia" 120
An inter and intra-laboratory comparison of breath 13CO2 . 119
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. 119
Autoantibodies reacting with gastric antigens in Helicobacter pylori gastritis of dyspeptic children 118
Pseudotumoural lesion of the abdominal wall due to a fishbone migration 118
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicenter study. 118
The augmenter of liver regeneration induces mithochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mithochondria. 117
"Alterazioni dello stato nutrizionale" 117
Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report 117
I breath tests nell’ insufficienza panctreatica, nelle malattie epatiche e nell’ alitosi. 116
Circadian rhythm of hepatic estrogen receptors. 115
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost-effectiveness 115
I nucleotidi ciclici (cAMP e cGMP) nell' ascite come markers di recidiva da carcinoma ovarico. 115
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV seronegative pregnant women: a 24 month prospective study. 114
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses. 114
A life threatning event following the injection of a microbubble contrast agent for ultrasonography. 114
Liver damage onset after a single infliximab administration in a patient with refractory ulcerative colitis 113
Malattia da reflusso gastro-esofageo e dispepsia non ulcerosa. 113
A new semiquantitative method of quantifying Helicobacter pylori antigen in stools 112
Cyclic nucleotides in ascites from ovarian carcinoma 112
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori: a multicenter study. 111
There is a role for sequential in sequential anti-H. pylori therapy? (Reply of the authors). 110
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori 109
The pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated to diverticula suggests a truly autonomous clinical entity. 108
Epidemiology of gastroesophageal reflux 108
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrintestinal symptoms 107
Incidence and risk factors of duodenal ulcer 106
Campylobacter fetus bacteriemia in an immunocompromised patient: a case report and review of literature. 106
Malnutrizione in Gastroenterologia. 106
A oral Tacrolimus long-term therapy in parients with Crohn’s disease and steroid resistance 106
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. 106
Anisakis pegreffi etiological agent of gastric infections in two Italian women. 105
Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. 105
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 105
Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection. 105
Immunohistochemical detection of Helicobacter Pylori vacuolating cytoxin in the hepatocytes of patients with isolated hypertransaminasemia 105
A third-line levofoxacin-based rescue therapy for Helicobacter pylori eradication. 104
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits 103
Update on Helicobacter pylori research. Malignancies. 102
Immunohistostaining of hepatitis C virus (HCV) non-structural protein 4 (NS 4) in ependymocytes of uninfected mice: an antigenic mimicry? 102
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. 102
Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation 101
Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice 100
Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 100
Effect of Lactobacillus reuteri on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy in children: a randomised clinical trial 100
Claritromycin resistance and Helicobacter pylori genotypes in Italy. 100
Effect of eradicating therapy on cell proliferation in Helicobacter pylori-related lesions 100
Tumor necrosis alpha serum levels parallels isolated hypertransaminasemia in the third trimester of pregnancy 100
Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? 100
Gastrospirillum hominis and human chronic gastritis 99
Estrogens, androgens and EGF receptor expression in gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine. 99
Improved Efficacy of 10 Day Sequential Treatment For Helicobacter Pylori Eradication In Children: A Randomised Trial. 99
Reflux symptoms in professional opera choristers. 99
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. 99
Two new treatment regimens for Helicobacter pilori eradication: a randomised study 99
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. 99
ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis. 98
“Mycophenolate mofetil in the treatment of autoimmune hcv-associated haematological disorders showing steroid resistance or dependence.” J Viral Hepat 98
Role of different clarithromycin resistance genotypes on Helicobacter pylori eradication. 97
Tumour necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 97
Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis 96
Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. 96
Celiac plexus under endoscopy ultrasonographic guidance complication. 96
Life threatening adverse event after injection of microbubble contrast agent for abdominal ultrasonography: first report. 96
Lupus nephritis improvement after anti-tumour necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn’s disease: a case report. 96
Ruolo attuale e progressi tecnologici dell’ecografia transaddominale nell’ imaging delle vie biliari 96
TUMOUR NECROSIS FACTOR ALPHA DOWNREGULATION AND BASIC FIBROBLAST GROWTH FACTOR/SYNDECAN 1 LINK: A POSSIBLE MOLECULAR PATHWAY OF MUCOSAL HEALING IN ULCERATIVE COLITIS 95
The prolongation of triple therapy for Helicobacter pylori does not allows reaching therapeutic outcome of sequential scheme: a prospective, randomized study. 95
Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis. 95
High eradication rates for Helicobacter pylori with a new sequential treatment. 94
Helicobacter species in liver and biliary diseases. 94
Effects of ranitidine: a short-term clinical trial for duodenal ulcer treatment using two different types of oral administration. Serum prolactin stimulation after bolus injection. 94
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. 94
Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. 94
Gastro-esophageal reflux disease and lactose malabsorption: casual comorbidity or neglected association? 94
Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. 93
Endoultrasonographic guided alcohol lavage of a pancreatic fluid collection: a case report 93
Small intestinal contrast ultrasonograpy based scoring system: a promising approach for the diagnosis and follow-up of celiac disease. 93
Worldwide H. pylori antibiotic resistance: a systematic review. 93
Helicobacter Heilmannii gastritis: a histological and immunohistochemical trait 92
Tumor necrosis factor alpha in segmental colitis associated with diverticula. 92
“Probiotic Multistrain Treatment May Eradicate Helicobacter pylori from the Stomach of Dyspeptics: A Placebo-Controlled Pilot Study.” Inflamm Allergy Drug Targets. 2012 Jun 1;11(3):244-9 92
Pathways and gene expression profiles in hepatocellular carcinoma 92
Pattern of apoptosis in Crohn’ s disease: a singular aspect. 91
Totale 10.962
Categoria #
all - tutte 69.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 157 5 14
2021/2022729 147 0 1 10 62 30 35 66 94 69 41 174
2022/20233.441 250 125 114 272 279 387 23 240 1.550 22 84 95
2023/2024454 111 26 22 15 57 149 1 28 0 5 0 40
2024/20251.811 94 39 98 90 94 310 146 142 483 55 131 129
2025/20262.772 184 123 271 396 106 162 891 365 164 110 0 0
Totale 14.704